Skip to content

Clinical trials

Phase 3 Carcinoma, Squamous Cell trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Squamous Cell Phase: Phase 3 Country / region: Australia Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20161
20171
20181
20191
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AVEO Pharmaceuticals, Inc.1
Ariad Pharmaceuticals1
Genzyme, a Sanofi Company1
Incyte Corporation1
Innovent Biologics (Suzhou) Co. Ltd.1
Merck Sharp & Dohme LLC1
Pfizer1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Squamous Cell8
Carcinoma, Large Cell3
Carcinoma, Non-Small-Cell Lung3
Adenocarcinoma2
Neoplasm Metastasis2
Recurrence2
Anus Neoplasms1
Carcinoma1
Carcinoma, Adenosquamous1
Esophageal Diseases1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.